Rigel Pharmaceuticals Inc (RIGL)

R&D Expenses

$43.68M

TTM · Period ending: · USD

RIGL logo

RIGL R&D Expenses

Latest reported$43.68M
RIGL TTM R&D Expenses ($32.03M → $43.68M)
High-resolution chart · PNG

RIGL r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
46,798,000
38,011,000
32,034,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.